Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04438174 · ClinicalTrials.gov registry record · Phase 1
Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds
A Phase 1 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT04438174 is a Phase 1 study that was terminated before completion, run by University of Utah. The registered enrollment target is 1 participants.
The verdict
NCT04438174, a Phase 1 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
A prospective randomized controlled study to determine the safety and feasibility of using processed amniotic fluid (pAF) to expedite healing in chronic wounds.
Interventions
- DRUG Processed Amniotic Fluid
- OTHER Standard of Care Wound Treatment Regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-08 |
| Est. Completion | 2023-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04438174
The ClinicalTrials.gov registry entry for NCT04438174 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Processed Amniotic Fluid is the first listed.
NCT04438174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04438174 about?
NCT04438174 is a clinical study titled "Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds". A prospective randomized controlled study to determine the safety and feasibility of using processed amniotic fluid (pAF) to expedite healing in chronic wounds.
What is the current status of trial NCT04438174?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2022-08. Estimated completion is 2023-03.
What interventions are being tested in trial NCT04438174?
The interventions under investigation include: Processed Amniotic Fluid (DRUG), Standard of Care Wound Treatment Regimen (OTHER).
Who is sponsoring clinical trial NCT04438174?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.